HMPL-506, a novel, highly potent and differentiated menin-MLL inhibitor for the treatment of MLL- rearrangedand NPM1mutant acute leukemia in preclinical models
CANCER RESEARCH(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2024)